Cervical Cancer Doctors Abroad — Page 3

Professor Turkan Ozturk Topcu is a medical oncology specialist at Valued Med Hub Hospitals with significant international training in managing complex malignancies.

• Trained at the MD Anderson Cancer Center in the USA, a world-leading oncology institution
• Completed a clinical programme at the Sunnybrook Odette Cancer Center Breast Cancer Clinic in Canada
• Specialises in gynaecological oncology, focusing on uterine and cervical cancer treatment
• Expertise includes tailored chemotherapy and targeted drug therapies for solid tumours
• Active researcher with advanced training from the Moffit Cancer Center in the USA

The doctor is an oncologist specializing in the treatment of breast, lung, and gastrointestinal cancers. Currently, the doctor practices at Istinye Liv University Hospital.

With a career spanning multiple esteemed institutions, the doctor has served as an Internal Medicine Specialist at Malatya State Hospital, a physician at Ankara Oncology Clinic, and a member of the Oncology Department at Erzurum Regional Training and Research Hospital.

The doctor graduated from the Faculty of Medicine at Selcuk University and achieved the title of Associate Professor in 2016.

Associate Professor Yusuf Acikgoz is a specialist medical oncologist with global experience, including a research stint at Ohio State University in the United States.

• Treats cervical cancer using established international drug protocols
• Involved as an investigator in major Phase III clinical oncology trials
• Member of the American Society of Clinical Oncology (ASCO)
• Completed specialised immuno-oncology training through the Central European Cooperative Oncology Group
• Recognised by the American ECFMG for meeting international medical education standards

Professor Cemil Bilir is a leading medical oncologist at VM Medical Park Pendik who specialises in chemotherapy and targeted drug protocols for gynaecological cancers.

• Trained at the Cleveland Clinic in the United States, focusing on complex internal medicine rotations
• Researches nanomedicine at Northeastern University to improve how cancer drugs reach tumours
• Holds a PhD in inorganic chemistry to better understand how chemotherapy agents interact with the body
• Active member of the European Society for Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO)

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Associate Professor Nail Paksoy is a board-certified medical oncologist who specialises in immunotherapy and targeted clinical protocols at Medipol Bahçelievler University Hospital.

• Holds ESMO Board Certification in Medical Oncology, an international mark of excellence from the European Society for Medical Oncology
• Active sub-investigator in international clinical trials for immunotherapy drugs like pembrolizumab and dostarlimab
• Specialises in desensitisation protocols, helping patients safely continue essential chemotherapy despite previous allergic reactions
• Published researcher on the efficacy of novel drug combinations for advanced solid tumours

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Professor Mustafa Serkan Alemdar is a medical oncology specialist at the Medical Park Antalya Hospital Complex with deep roots in university-level clinical research.

• Trained at Akdeniz University across internal medicine and medical oncology
• Researched oncology protocols at İnönü University Faculty of Medicine
• Managed complex cases at Antalya Training and Research Hospital
• Focuses on systemic therapies for gynaecological malignancies